Melanoma/Skin Cancer News

Among individuals who have undergone solid organ transplantation, viral infections and exposure to ultraviolet sunlight were associated with the highest risks for skin cancers, according to a study.

Research suggests the gut microbiome plays a role in response to cancer immunotherapy, according to a study published in Nature Medicine.

A phase 3 trial designed to assess the addition of bempegaldesleukin to nivolumab for previously untreated unresectable or metastatic melanoma failed to meet its primary endpoint, according to the agents’ manufacturers.

In a research collaboration with Mayo Clinic, nanomedical company NaNotics LLC plans to develop and assess a novel subtractive nanoparticle for use in cancer treatment.

Poor differentiation and deep invasion are the most common risk factors for metastatic cutaneous squamous cell carcinoma following diameter and thickness, according to a study.

Daily electronic patient-reported outcome assessments may provide valuable insight into symptom management among patients with cancer undergoing antineoplastic treatment, according to a study published in JAMA Network Open.

Merkel cell carcinoma has a recurrence rate of 40%, with 90% reoccurring within the first 3 years, according to a study.

Fox Chase Cancer Center announced two faculty appointments.

The use of artificial intelligence to triage and identify certain skin cancers had results similar to dermatologists’ identifications, according to a study.

The FDA placed a clinical hold on a phase 1 trial of LB1901, a chimeric antigen receptor T-cell therapy for treatment of adults with relapsed or refractory T-cell lymphoma.